Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era

por Coyle, Patricia K., Gocke, Anne, Vignos, Megan, Newsome, Scott D.
Publicado 2021

Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era

por Coyle, Patricia K., Gocke, Anne, Vignos, Megan, Newsome, Scott D.
Publicado 2021

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis

por Yang, Yuhong, Gocke, Anne R., Lovett-Racke, Amy, Drew, Paul D., Racke, Michael K.
Publicado 2008

Vaccine response in people with multiple sclerosis treated with fumarates

por Tremblay, Matthew A., Vukusic, Sandra, Shanmugasundaram, Mathura, Bozin, Ivan, Levin, Seth, Gocke, Anne, Wipfler, Peter
Publicado 2023

Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes

por Hu, Lina, Wang, Tongguang, Gocke, Anne R., Nath, Avindra, Zhang, Hao, Margolick, Joseph B., Whartenby, Katharine A., Calabresi, Peter A.
Publicado 2013

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

por Ghoreschi, Kamran, Brück, Jürgen, Kellerer, Christina, Deng, Caishu, Peng, Haiyan, Rothfuss, Oliver, Hussain, Rehana Z., Gocke, Anne R., Respa, Annedore, Glocova, Ivana, Valtcheva, Nadejda, Alexander, Eva, Feil, Susanne, Feil, Robert, Schulze-Osthoff, Klaus, Rupec, Rudolf A., Lovett-Racke, Amy E., Dringen, Ralf, Racke, Michael K., Röcken, Martin
Publicado 2011

Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling

por Hu, Wei, Nessler, Stefan, Hemmer, Bernhard, Eagar, Todd N., Kane, Lawrence P., Leliveld, S. Rutger, Müller-Schiffmann, Andreas, Gocke, Anne R., Lovett-Racke, Amy, Ben, Li-Hong, Hussain, Rehana Z., Breil, Andreas, Elliott, Jeffrey L., Puttaparthi, Krishna, Cravens, Petra D., Singh, Mahendra P., Petsch, Benjamin, Stitz, Lothar, Racke, Michael K., Korth, Carsten, Stüve, Olaf
Publicado 2010